Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration

Klodeta Kura(MSD (UK) Limited (United Kingdom)), Roy M. Anderson(NIHR Imperial Biomedical Research Centre), James E. Truscott(Medical Research Council), T. Déirdre Hollingsworth(University of Oxford), Jaspreet Toor(Imperial College London), Benjamin Collyer(Imperial College London), Matt J. Keeling(University of Warwick)
Cited by 17


Related Papers